Table 3.
Comparison of echocardiographic data between thalassemic patients (n=46) and control group (n=39)
| Thalassemic | Controls | p-value | |
|---|---|---|---|
|
|
|||
| LV Mass (g) | 77,6±16,3 | 88±24,3 | 0,02 |
| LA Area (cm2) | 19,8±3 | 16,8±1,4 | <0,0001 |
| LVEDD (mm) | 47,9±4 | 49,2±6 | 0,25 |
| LVESD (mm) | 31,2±34,1 | 29,4±4,2 | 0,05 |
| Indexed LVEDD (mm/m2) | 29,7±3 | 28,2±1,6 | 0,008 |
| IVS (mm) | 8,1±1 | 9,2±1,4 | 0,0001 |
| LVPW (mm) | 7,8±0,8 | 8,6±1,2 | 0,0004 |
| RA Area (cm2) | 16,4±3 | 15,2±1,2 | 0,02 |
| RVTS Area (cm2) | 10,7±2,9 | 9,4±2,8 | 0,06 |
| RVTD Area (cm2) | 21,3±5,2 | 20,1±5,3 | 0,27 |
LA= left atrium; LVEDD= left ventricle end-diastolic diameter; LVESD= Left ventricle end-systolic diameter; IVS= interventricular septum; LVPW= left ventricle posterior wall; RA= right atrium; RVTS= right ventricle tele-systolic; RVTD= right ventricle tele-diastolic.